SCHEMBL31716019

SCHEMBL31716019

O=c1[nH]c(Cc2ccc(-c3cc(F)cc(F)c3)nc2)nc2cc(O)c(Cl)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.38
▸ RNASEH1 O60930 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ TUBB4A P04350 1/20 0.34
▸ TUBB P07437 1/20 0.34
▸ TUBA3C P0DPH7 1/20 0.34
▸ TUBA1B P68363 1/20 0.34
▸ TUBA4A P68366 1/20 0.34
▸ TUBB4B P68371 1/20 0.34
▸ TUBB3 Q13509 1/20 0.34
▸ TUBB2A Q13885 1/20 0.34
▸ TUBB8 Q3ZCM7 1/20 0.34
▸ TUBA3E Q6PEY2 1/20 0.34
▸ TUBA1A Q71U36 1/20 0.34
▸ TUBA1C Q9BQE3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716260 0.89 PDE5A (0.36) PDE5ARNASEH1KMT2ALMNAKDM4E
SCHEMBL31717042 0.86 LMNA (0.43) RNASEH1LMNAKDM4EMAPTALDH1A1
SCHEMBL31716279 0.80 USP2 (0.39) KDM4EPOLBTNKSALDH1A1HPGD
SCHEMBL31716946 0.79 LMNA (0.44) RNASEH1LMNAKDM4EALDH1A1GAA
SCHEMBL31715976 0.78 KDM4E (0.49) KMT2ALMNAKDM4ETUBB4ATUBB
SCHEMBL31716050 0.78 LMNA (0.43) RNASEH1TRPV1LMNAKDM4EMAPT
SCHEMBL31716955 0.78 LMNA (0.43) LMNAKDM4EMAPTALDH1A1GAA
SCHEMBL31716038 0.77 KDM4E (0.37) RNASEH1KMT2ALMNAKDM4EGAA
SCHEMBL31716882 0.77 MAPK1 (0.46) LMNAKDM4EALDH1A1GAAROCK2
SCHEMBL31716323 0.77 PIM1 (0.37) PDE5AKMT2ALMNATUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback